Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |